Global Rituximab Drug Market Growth 2022-2028
- LP 4871440
- 74 Pages
- February 2022
- Pharmaceuticals
The United States Rituximab Drug market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Rituximab Drug market, reaching US$ million by the year 2028. As for the Europe Rituximab Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Rituximab Drug players cover Roche, , , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Rituximab Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
10ml
50ml
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hematological Cancers
Autoimmune Diseases
Organ Transplants
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Roche
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Rituximab Drug Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Rituximab Drug by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Rituximab Drug by Country/Region, 2017, 2022 & 2028
2.2 Rituximab Drug Segment by Type
2.2.1 10ml
2.2.2 50ml
2.3 Rituximab Drug Sales by Type
2.3.1 Global Rituximab Drug Sales Market Share by Type (2017-2022)
2.3.2 Global Rituximab Drug Revenue and Market Share by Type (2017-2022)
2.3.3 Global Rituximab Drug Sale Price by Type (2017-2022)
2.4 Rituximab Drug Segment by Application
2.4.1 Hematological Cancers
2.4.2 Autoimmune Diseases
2.4.3 Organ Transplants
2.5 Rituximab Drug Sales by Application
2.5.1 Global Rituximab Drug Sale Market Share by Application (2017-2022)
2.5.2 Global Rituximab Drug Revenue and Market Share by Application (2017-2022)
2.5.3 Global Rituximab Drug Sale Price by Application (2017-2022)
3 Global Rituximab Drug by Company
3.1 Global Rituximab Drug Breakdown Data by Company
3.1.1 Global Rituximab Drug Annual Sales by Company (2020-2022)
3.1.2 Global Rituximab Drug Sales Market Share by Company (2020-2022)
3.2 Global Rituximab Drug Annual Revenue by Company (2020-2022)
3.2.1 Global Rituximab Drug Revenue by Company (2020-2022)
3.2.2 Global Rituximab Drug Revenue Market Share by Company (2020-2022)
3.3 Global Rituximab Drug Sale Price by Company
3.4 Key Manufacturers Rituximab Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Rituximab Drug Product Location Distribution
3.4.2 Players Rituximab Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Rituximab Drug by Geographic Region
4.1 World Historic Rituximab Drug Market Size by Geographic Region (2017-2022)
4.1.1 Global Rituximab Drug Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Rituximab Drug Annual Revenue by Geographic Region
4.2 World Historic Rituximab Drug Market Size by Country/Region (2017-2022)
4.2.1 Global Rituximab Drug Annual Sales by Country/Region (2017-2022)
4.2.2 Global Rituximab Drug Annual Revenue by Country/Region
4.3 Americas Rituximab Drug Sales Growth
4.4 APAC Rituximab Drug Sales Growth
4.5 Europe Rituximab Drug Sales Growth
4.6 Middle East & Africa Rituximab Drug Sales Growth
5 Americas
5.1 Americas Rituximab Drug Sales by Country
5.1.1 Americas Rituximab Drug Sales by Country (2017-2022)
5.1.2 Americas Rituximab Drug Revenue by Country (2017-2022)
5.2 Americas Rituximab Drug Sales by Type
5.3 Americas Rituximab Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Rituximab Drug Sales by Region
6.1.1 APAC Rituximab Drug Sales by Region (2017-2022)
6.1.2 APAC Rituximab Drug Revenue by Region (2017-2022)
6.2 APAC Rituximab Drug Sales by Type
6.3 APAC Rituximab Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Rituximab Drug by Country
7.1.1 Europe Rituximab Drug Sales by Country (2017-2022)
7.1.2 Europe Rituximab Drug Revenue by Country (2017-2022)
7.2 Europe Rituximab Drug Sales by Type
7.3 Europe Rituximab Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Rituximab Drug by Country
8.1.1 Middle East & Africa Rituximab Drug Sales by Country (2017-2022)
8.1.2 Middle East & Africa Rituximab Drug Revenue by Country (2017-2022)
8.2 Middle East & Africa Rituximab Drug Sales by Type
8.3 Middle East & Africa Rituximab Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Rituximab Drug
10.3 Manufacturing Process Analysis of Rituximab Drug
10.4 Industry Chain Structure of Rituximab Drug
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Rituximab Drug Distributors
11.3 Rituximab Drug Customer
12 World Forecast Review for Rituximab Drug by Geographic Region
12.1 Global Rituximab Drug Market Size Forecast by Region
12.1.1 Global Rituximab Drug Forecast by Region (2023-2028)
12.1.2 Global Rituximab Drug Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Rituximab Drug Forecast by Type
12.7 Global Rituximab Drug Forecast by Application
13 Key Players Analysis
13.1 Roche
13.1.1 Roche Company Information
13.1.2 Roche Rituximab Drug Product Offered
13.1.3 Roche Rituximab Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Roche Main Business Overview
13.1.5 Roche Latest Developments
14 Research Findings and Conclusion
Table 1. Rituximab Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Rituximab Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 10ml
Table 4. Major Players of 50ml
Table 5. Global Rituximab Drug Sales by Type (2017-2022) & (K Units)
Table 6. Global Rituximab Drug Sales Market Share by Type (2017-2022)
Table 7. Global Rituximab Drug Revenue by Type (2017-2022) & ($ million)
Table 8. Global Rituximab Drug Revenue Market Share by Type (2017-2022)
Table 9. Global Rituximab Drug Sale Price by Type (2017-2022) & (USD/Unit)
Table 10. Global Rituximab Drug Sales by Application (2017-2022) & (K Units)
Table 11. Global Rituximab Drug Sales Market Share by Application (2017-2022)
Table 12. Global Rituximab Drug Revenue by Application (2017-2022)
Table 13. Global Rituximab Drug Revenue Market Share by Application (2017-2022)
Table 14. Global Rituximab Drug Sale Price by Application (2017-2022) & (USD/Unit)
Table 15. Global Rituximab Drug Sales by Company (2020-2022) & (K Units)
Table 16. Global Rituximab Drug Sales Market Share by Company (2020-2022)
Table 17. Global Rituximab Drug Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Rituximab Drug Revenue Market Share by Company (2020-2022)
Table 19. Global Rituximab Drug Sale Price by Company (2020-2022) & (USD/Unit)
Table 20. Key Manufacturers Rituximab Drug Producing Area Distribution and Sales Area
Table 21. Players Rituximab Drug Products Offered
Table 22. Rituximab Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Rituximab Drug Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Rituximab Drug Sales Market Share Geographic Region (2017-2022)
Table 27. Global Rituximab Drug Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Rituximab Drug Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Rituximab Drug Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Rituximab Drug Sales Market Share by Country/Region (2017-2022)
Table 31. Global Rituximab Drug Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Rituximab Drug Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Rituximab Drug Sales by Country (2017-2022) & (K Units)
Table 34. Americas Rituximab Drug Sales Market Share by Country (2017-2022)
Table 35. Americas Rituximab Drug Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Rituximab Drug Revenue Market Share by Country (2017-2022)
Table 37. Americas Rituximab Drug Sales by Type (2017-2022) & (K Units)
Table 38. Americas Rituximab Drug Sales Market Share by Type (2017-2022)
Table 39. Americas Rituximab Drug Sales by Application (2017-2022) & (K Units)
Table 40. Americas Rituximab Drug Sales Market Share by Application (2017-2022)
Table 41. APAC Rituximab Drug Sales by Region (2017-2022) & (K Units)
Table 42. APAC Rituximab Drug Sales Market Share by Region (2017-2022)
Table 43. APAC Rituximab Drug Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Rituximab Drug Revenue Market Share by Region (2017-2022)
Table 45. APAC Rituximab Drug Sales by Type (2017-2022) & (K Units)
Table 46. APAC Rituximab Drug Sales Market Share by Type (2017-2022)
Table 47. APAC Rituximab Drug Sales by Application (2017-2022) & (K Units)
Table 48. APAC Rituximab Drug Sales Market Share by Application (2017-2022)
Table 49. Europe Rituximab Drug Sales by Country (2017-2022) & (K Units)
Table 50. Europe Rituximab Drug Sales Market Share by Country (2017-2022)
Table 51. Europe Rituximab Drug Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Rituximab Drug Revenue Market Share by Country (2017-2022)
Table 53. Europe Rituximab Drug Sales by Type (2017-2022) & (K Units)
Table 54. Europe Rituximab Drug Sales Market Share by Type (2017-2022)
Table 55. Europe Rituximab Drug Sales by Application (2017-2022) & (K Units)
Table 56. Europe Rituximab Drug Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Rituximab Drug Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Rituximab Drug Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Rituximab Drug Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Rituximab Drug Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Rituximab Drug Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Rituximab Drug Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Rituximab Drug Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Rituximab Drug Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Rituximab Drug
Table 66. Key Market Challenges & Risks of Rituximab Drug
Table 67. Key Industry Trends of Rituximab Drug
Table 68. Rituximab Drug Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Rituximab Drug Distributors List
Table 71. Rituximab Drug Customer List
Table 72. Global Rituximab Drug Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Rituximab Drug Sales Market Forecast by Region
Table 74. Global Rituximab Drug Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Rituximab Drug Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Rituximab Drug Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Rituximab Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Rituximab Drug Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Rituximab Drug Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Rituximab Drug Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Rituximab Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Rituximab Drug Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Rituximab Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Rituximab Drug Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Rituximab Drug Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Rituximab Drug Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Rituximab Drug Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Rituximab Drug Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Rituximab Drug Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Rituximab Drug Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Rituximab Drug Revenue Market Share Forecast by Application (2023-2028)
Table 92. Roche Basic Information, Rituximab Drug Manufacturing Base, Sales Area and Its Competitors
Table 93. Roche Rituximab Drug Product Offered
Table 94. Roche Rituximab Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 95. Roche Main Business
Table 96. Roche Latest Developments
List of Figures
Figure 1. Picture of Rituximab Drug
Figure 2. Rituximab Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Rituximab Drug Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Rituximab Drug Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Rituximab Drug Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 10ml
Figure 10. Product Picture of 50ml
Figure 11. Global Rituximab Drug Sales Market Share by Type in 2021
Figure 12. Global Rituximab Drug Revenue Market Share by Type (2017-2022)
Figure 13. Rituximab Drug Consumed in Hematological Cancers
Figure 14. Global Rituximab Drug Market: Hematological Cancers (2017-2022) & (K Units)
Figure 15. Rituximab Drug Consumed in Autoimmune Diseases
Figure 16. Global Rituximab Drug Market: Autoimmune Diseases (2017-2022) & (K Units)
Figure 17. Rituximab Drug Consumed in Organ Transplants
Figure 18. Global Rituximab Drug Market: Organ Transplants (2017-2022) & (K Units)
Figure 19. Global Rituximab Drug Sales Market Share by Application (2017-2022)
Figure 20. Global Rituximab Drug Revenue Market Share by Application in 2021
Figure 21. Rituximab Drug Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Rituximab Drug Revenue Market Share by Company in 2021
Figure 23. Global Rituximab Drug Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Rituximab Drug Revenue Market Share by Geographic Region in 2021
Figure 25. Global Rituximab Drug Sales Market Share by Region (2017-2022)
Figure 26. Global Rituximab Drug Revenue Market Share by Country/Region in 2021
Figure 27. Americas Rituximab Drug Sales 2017-2022 (K Units)
Figure 28. Americas Rituximab Drug Revenue 2017-2022 ($ Millions)
Figure 29. APAC Rituximab Drug Sales 2017-2022 (K Units)
Figure 30. APAC Rituximab Drug Revenue 2017-2022 ($ Millions)
Figure 31. Europe Rituximab Drug Sales 2017-2022 (K Units)
Figure 32. Europe Rituximab Drug Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Rituximab Drug Sales 2017-2022 (K Units)
Figure 34. Middle East & Africa Rituximab Drug Revenue 2017-2022 ($ Millions)
Figure 35. Americas Rituximab Drug Sales Market Share by Country in 2021
Figure 36. Americas Rituximab Drug Revenue Market Share by Country in 2021
Figure 37. United States Rituximab Drug Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Rituximab Drug Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Rituximab Drug Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Rituximab Drug Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Rituximab Drug Sales Market Share by Region in 2021
Figure 42. APAC Rituximab Drug Revenue Market Share by Regions in 2021
Figure 43. China Rituximab Drug Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Rituximab Drug Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Rituximab Drug Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Rituximab Drug Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Rituximab Drug Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Rituximab Drug Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Rituximab Drug Sales Market Share by Country in 2021
Figure 50. Europe Rituximab Drug Revenue Market Share by Country in 2021
Figure 51. Germany Rituximab Drug Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Rituximab Drug Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Rituximab Drug Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Rituximab Drug Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Rituximab Drug Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Rituximab Drug Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Rituximab Drug Revenue Market Share by Country in 2021
Figure 58. Egypt Rituximab Drug Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Rituximab Drug Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Rituximab Drug Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Rituximab Drug Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Rituximab Drug Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Rituximab Drug in 2021
Figure 64. Manufacturing Process Analysis of Rituximab Drug
Figure 65. Industry Chain Structure of Rituximab Drug
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
